# Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

> **NCT00699907** · PHASE2 · COMPLETED · sponsor: **University of Arizona** · enrollment: 127 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** flutamide

## Key facts

- **NCT ID:** NCT00699907
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2012-11
- **Final completion:** 2014-11
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2018-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699907, "Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00699907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*